News & Updates

Show Multimedia Only

Paracetamol safe to use during pregnancy: study

05 Feb 2026 by

The use of paracetamol during pregnancy does not appear to increase the likelihood of autism spectrum disorder (ASD), attention-deficit hyperactivity disorder (ADHD), or intellectual disability in children, according to the results of a systematic review and meta-analysis.

Paracetamol safe to use during pregnancy: study

05 Feb 2026

Acute gastroenteritis ups DGBI risk in children

04 Feb 2026

Disorders of gut-brain interaction (DGBIs) tend to develop more in children in acute gastroenteritis (AGE), according to a study. Moreover, an association is seen between AGE symptom severity and postinfectious (PI) DGBI.

Acute gastroenteritis ups DGBI risk in children

04 Feb 2026

Appendectomy a risk factor for nontyphoidal salmonella infection in children

31 Jan 2026

Children who underwent appendectomy are at increased risk of subsequent nontyphoidal salmonella infection, as shown in a study.

Appendectomy a risk factor for nontyphoidal salmonella infection in children

31 Jan 2026

Advanced maternal age linked to reduced risk of allergic diseases in early childhood

30 Jan 2026

Children born to older mothers appear to have a reduced likelihood of food allergy, wheezing, and house dust mite sensitization in early childhood, according to a study.

Advanced maternal age linked to reduced risk of allergic diseases in early childhood

30 Jan 2026

Original New Drug Application Approvals by US FDA (1-15 January 2026)

30 Jan 2026

New drug applications approved by US FDA as of 1-15 January 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 January 2026)

30 Jan 2026

Original New Drug Application Approvals by US FDA (16-31 January 2026)

30 Jan 2026

New drug applications approved by US FDA as of 16-31 January 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 January 2026)

30 Jan 2026

Saline spray clears obstructive sleep-disordered breathing symptoms for some kids

29 Jan 2026 by

Two 6-week courses of intranasal saline help resolve symptoms of obstructive sleep-disordered breathing (OSDB) for about half of the children in the MIST+ trial, with efficacy similar to that of intranasal steroid.

Saline spray clears obstructive sleep-disordered breathing symptoms for some kids

29 Jan 2026

New model predicts febrile UTI in children with VUR after CAP discontinuation

29 Jan 2026

Select children with persistent vesicoureteral reflux (VUR), especially those without voiding dysfunction, may choose to suspend continuous antibiotic prophylaxis (CAP), suggests a study, noting that a predictive monogram can aid in individualized decision-making.